174 related articles for article (PubMed ID: 21063505)
21. CTGF/CCN2 from Skeletal Muscle to Nervous System: Impact on Neurodegenerative Diseases.
Gonzalez D; Brandan E
Mol Neurobiol; 2019 Aug; 56(8):5911-5916. PubMed ID: 30689195
[TBL] [Abstract][Full Text] [Related]
22. Protocol for CRISPR/Cas Genome Editing for Investigating Cell Communication Network.
Okusha Y; Eguchi T
Methods Mol Biol; 2023; 2582():157-167. PubMed ID: 36370349
[TBL] [Abstract][Full Text] [Related]
23. CCN2/decorin interactions: a novel approach to combating fibrosis?
Leask A
J Cell Commun Signal; 2011 Aug; 5(3):249-50. PubMed ID: 21533889
[TBL] [Abstract][Full Text] [Related]
24. The CCN family of genes: a perspective on CCN biology and therapeutic potential.
Yeger H; Perbal B
J Cell Commun Signal; 2007 Dec; 1(3-4):159-64. PubMed ID: 18568428
[TBL] [Abstract][Full Text] [Related]
25. CTGF/CCN2 exerts profibrotic action in myoblasts via the up-regulation of sphingosine kinase-1/S1P3 signaling axis: Implications in the action mechanism of TGFβ.
Bruno G; Cencetti F; Pertici I; Japtok L; Bernacchioni C; Donati C; Bruni P
Biochim Biophys Acta; 2015 Feb; 1851(2):194-202. PubMed ID: 25457224
[TBL] [Abstract][Full Text] [Related]
26. Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan.
Gao R; Brigstock DR
J Biol Chem; 2004 Mar; 279(10):8848-55. PubMed ID: 14684735
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of CCN-family members in primary human bone marrow-derived mesenchymal stem cells during osteogenic, chondrogenic and adipogenic differentiation.
Schutze N; Noth U; Schneidereit J; Hendrich C; Jakob F
Cell Commun Signal; 2005 Mar; 3(1):5. PubMed ID: 15773998
[TBL] [Abstract][Full Text] [Related]
28. CCN proteins: opportunities for clinical studies-a personal perspective.
Yeger H
J Cell Commun Signal; 2023 Jun; 17(2):333-352. PubMed ID: 37195381
[TBL] [Abstract][Full Text] [Related]
29. CCN2: a novel, specific and valid target for anti-fibrotic drug intervention.
Leask A
Expert Opin Ther Targets; 2013 Sep; 17(9):1067-71. PubMed ID: 23848501
[TBL] [Abstract][Full Text] [Related]
30. Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation.
Kaasbøll OJ; Gadicherla AK; Wang JH; Monsen VT; Hagelin EMV; Dong MQ; Attramadal H
J Biol Chem; 2018 Nov; 293(46):17953-17970. PubMed ID: 30262666
[TBL] [Abstract][Full Text] [Related]
31. Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family.
Abd El Kader T; Kubota S; Janune D; Nishida T; Hattori T; Aoyama E; Perbal B; Kuboki T; Takigawa M
J Cell Commun Signal; 2013 Mar; 7(1):11-8. PubMed ID: 23065484
[TBL] [Abstract][Full Text] [Related]
32. CCN5/WISP2 and metabolic diseases.
Grünberg JR; Elvin J; Paul A; Hedjazifar S; Hammarstedt A; Smith U
J Cell Commun Signal; 2018 Mar; 12(1):309-318. PubMed ID: 29247377
[TBL] [Abstract][Full Text] [Related]
33. [Effects of CCN5 overexpression on the expression of alpha-SMA and collagen I in hepatic stellate cells and its mechanism].
Zhang CY; Xie X; Gao DS; Zhang CX
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Sep; 29(5):411-5. PubMed ID: 24386815
[TBL] [Abstract][Full Text] [Related]
34. Tissue distribution and transcriptional regulation of CCN5 in the heart after myocardial infarction.
Zolfaghari S; Kaasbøll OJ; Ahmed MS; Line FA; Hagelin EMV; Monsen VT; Attramadal H
J Cell Commun Signal; 2022 Sep; 16(3):377-395. PubMed ID: 34854055
[TBL] [Abstract][Full Text] [Related]
35. CTGF/CCN2 is an autocrine regulator of cardiac fibrosis.
Dorn LE; Petrosino JM; Wright P; Accornero F
J Mol Cell Cardiol; 2018 Aug; 121():205-211. PubMed ID: 30040954
[TBL] [Abstract][Full Text] [Related]
36. New strategy to control cell migration and metastasis regulated by CCN2/CTGF.
Aguiar DP; de Farias GC; de Sousa EB; de Mattos Coelho-Aguiar J; Lobo JC; Casado PL; Duarte ME; Abreu JG
Cancer Cell Int; 2014; 14():61. PubMed ID: 25120383
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta1 (TGFbeta1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism: statins with forskolin block TGFbeta1-induced CCN2/CTGF expression.
Black SA; Trackman PC
J Biol Chem; 2008 Apr; 283(16):10835-47. PubMed ID: 18287089
[TBL] [Abstract][Full Text] [Related]
38. CCN3/CCN2 regulation and the fibrosis of diabetic renal disease.
Riser BL; Najmabadi F; Perbal B; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC; Peterson DR
J Cell Commun Signal; 2010 Mar; 4(1):39-50. PubMed ID: 20195391
[TBL] [Abstract][Full Text] [Related]
39. Ten years later..
Perbal B
J Cell Commun Signal; 2009 Mar; 3(1):1-3. PubMed ID: 19370402
[TBL] [Abstract][Full Text] [Related]
40. Characterization of bone morphology in CCN5/WISP5 knockout mice.
Jiang J; Zhao G; Lyons KM
J Cell Commun Signal; 2018 Mar; 12(1):265-270. PubMed ID: 29396648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
